Literature Archives

All Studies Advanced Bronchoscopy Pleural Disease Airway Disorders Pulmonary Vascular ILD Lung Cancer COPD / Asthma General Pulmonology

Thorax Aug 14, 2026

Upstaging of screen-detected lung cancers during diagnostic assessment.

Study Takeaway

Relevant to the timing and diagnostic strategies utilized in bronchoscopic evaluation of screen-detected lung cancer.

Mullin ML; Verghese P; Khaw CR; Creamer A; Bhamani A; Prendecki R

IP Score: 6/10 View Analysis →

Chest Aug 5, 2026

Systematic review and meta-analysis of FDG PET-CT for nodal staging of part-solid lung adenocarcinomas.

Study Takeaway

Relevant for staging and selecting patients who may require bronchoscopic mediastinal staging (like EBUS).

Choy PM; Wong HYA; Lim EKS; Hare SS; Patel ARC; Pencharz D

IP Score: 6/10 View Analysis →

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jul 30, 2026

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Study Takeaway

Provides broader context on multidisciplinary management of NSCLC that impacts staging and biopsy referrals.

Meyer ML; Peters S; Borghaei H; Cascone T; Dacic S; Faivre-Finn C

IP Score: 6/10 View Analysis →

Chest Jul 28, 2026

Development and Multi-center Validation of a Breathomics-Based Triage Tool for Lung Cancer: A Prospective Study of 5,214 Participants.

Study Takeaway

Non-invasive triage tools may eventually alter referral patterns for diagnostic bronchoscopy and nodule management.

Qin J; Sun M; Li X; Duan X; Li Y; Ma H

IP Score: 6/10 View Analysis →

American journal of respiratory and critical care medicine Jul 27, 2026

Tool In Lesion- But Still Off Target: A Call of Concern for Lung Cancer Screening.

Study Takeaway

Highlights ongoing limitations in targeting peripheral pulmonary lesions during screening and bronchoscopy.

Schwartz J; Murn M; Laniado I; Studts JL; Bade BC

IP Score: 6/10 View Analysis →

Chest Jul 16, 2026

Evolving Lung Cancer Navigator Practice Through Targeted Professional Development: A Long-term Outcomes Analysis.

Study Takeaway

Highlights the importance of multidisciplinary coordination in the IP lung cancer diagnostic pathway.

Lloyd SJ; Mortman MF; Monahan PO; Slaven JE; Lemery C; Podsiad M

IP Score: 6/10 View Analysis →

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jul 14, 2026

Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer.

Study Takeaway

Relevant to the diagnostic and monitoring pathway for lung cancer patients often managed by IP for biopsy and staging.

Cui Q; Zhang JT; Yin H; Zhang KP; Xu J; Xu FP

IP Score: 6/10 View Analysis →

Chest Jul 1, 2026

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Study Takeaway

Relevant for IP clinicians involved in lung cancer screening programs and the management of screen-detected nodules.

Liu H; Yan S; Liu P; Zhang C; Wang Q; Shen Q

IP Score: 6/10 View Analysis →

Thorax Jun 25, 2026

Comparative cost-effectiveness of screening for lung cancer using different risk scores and thresholds: the Yorkshire Lung Screening Trial.

Study Takeaway

Optimizing screening criteria will likely increase the volume of screen-detected nodules requiring IP diagnostic intervention.

Zhang Y; Hinde S; Marshall CS; Hancock N; Simmonds I; Soares M

IP Score: 6/10 View Analysis →

Thorax Jun 17, 2026

Sex differences in immunotherapy for lung cancer: balance or bias?

Study Takeaway

Understanding sex-based differences in immunotherapy response is increasingly important for IP clinicians involved in the diagnostic and staging pathways of lung cancer.

Mascarenhas E; Cordeiro de Lima VC

IP Score: 6/10 View Analysis →

Thorax Jun 15, 2026

Multimodality curative-intent treatment in NSCLC: an unprecedented era of change 2017-2025.

Study Takeaway

IPs must stay updated on these systemic therapy shifts as they influence the timing and necessity of diagnostic and staging bronchoscopy in the multimodality care pathway.

Evison M; Ahmed T; Chitnis M; Ward R; Netto D; Cove-Smith L

IP Score: 6/10 View Analysis →

Chest May 29, 2026

Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions.

Study Takeaway

Highlights the importance of multidisciplinary management for incidental findings detected during lung cancer screening, which often leads to IP referral for diagnostic biopsy.

Revel MP; Goo JM; Vliegenthart R; Silva M; Snoeckx A

IP Score: 7/10 View Analysis →

PAGE archives Next Page →